Dexcom (DXCM) Shares Repurchased (2023 - 2025)

Dexcom (DXCM) has 3 years of Shares Repurchased data on file, last reported at $312.8 million in Q4 2025.

• Quarterly Shares Repurchased changed N/A year-over-year to $312.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 billion (changed 0.0% YoY) and the FY2025 annual result came in at $500.0 million, down 33.33% from the prior year.
• Shares Repurchased advanced to $312.8 million in Q4 2025 per DXCM's latest filing, from $187.2 million in the prior quarter.
• Across five years, Shares Repurchased topped out at $750.0 million in Q3 2024 and bottomed at $187.2 million in Q3 2025.
• The 3-year median for Shares Repurchased is $406.4 million (2023), against an average of $437.5 million.
• Peak annual rise in Shares Repurchased reached 75.04% in 2025, while the deepest fall reached 75.04% in 2025.
• Tracing DXCM's Shares Repurchased over 3 years: stood at $500.0 million in 2023, then jumped by 50.0% to $750.0 million in 2024, then plunged by 58.29% to $312.8 million in 2025.
• Per Business Quant, the three latest DXCM Shares Repurchased figures stand at $312.8 million (Q4 2025), $187.2 million (Q3 2025), and $750.0 million (Q3 2024).

Peer Comparison